PDCD1 and non-small cell lung carcinoma: When combined with PD-1 inhibitors, carbon ion therapy may be more effective at treating NSCLC because it produces complex cluster damage in tumor cells' DNA that is primarily composed of double-strand breaks and has a higher relative biological effectiveness (RBE) than X-ray.